This lower expression is correlated with a poor prognosis and SETD2 overexpression in GC cell lines significantly inhibited cell proliferation, migration, and invasion hence reinforcing the hypothesized role of tumor suppressor of the SETD2 gene in GC [85]. The gene discussed is SETD2; the disease is gastric cancer.